ICD-10-CM Billable Code

L74.511

Primary focal hyperhidrosis, face

Clinical Classification Guidelines

Medical Intelligence & Overview

Primary focal hyperhidrosis of the face is a condition characterized by excessive sweating localized to one specific area—the face. This condition can cause significant discomfort and impact daily activities, social interactions, and self-esteem. Unlike generalized sweating, which affects large body parts or the entire body, primary focal hyperhidrosis is limited to a specific region and typically begins in adolescence or early adulthood. Recognizing the symptoms and understanding its causes can help manage this condition effectively.

Causes & Symptoms

Clinical Causes: Overactive sweat glands in the facial region due to nerve signals that send excessive impulses to sweat glands Genetic predisposition, often running in families Idiopathic origin, meaning no specific cause can be identified Possible underlying nervous system abnormalities that cause abnormal sweating signals Emotional triggers such as anxiety, stress, or embarrassment can exacerbate symptoms

Key Symptoms: Persistent excessive sweating limited to the face, which may include the forehead, cheeks, chin, or upper lip Sweating occurs without exposure to high temperatures or physical activity Episodes may be triggered or worsened by emotional states like anxiety or nervousness Skin may appear moist or clammy in the affected area Possible skin irritation or inflammation due to constant moisture Social discomfort or difficulty engaging in activities due to visible sweating

Diagnostic & Treatment

Diagnosis Path: The diagnosis of primary focal hyperhidrosis of the face typically involves a detailed medical history and physical examination. Physicians may ask about the onset of symptoms, triggers, family history, and the impact on daily life. In some cases, tests such as the starch-iodine test (Minor's test) might be performed to identify the precise area of excessive sweating. Since other causes of facial sweating can include hormonal imbalances or neurological conditions, additional investigations may be undertaken to rule out secondary causes.

Treatment Protocols: Treatment options for primary focal hyperhidrosis of the face aim to reduce sweating and improve quality of life. These may include: - **Topical treatments:** Antiperspirants containing aluminum chloride can help decrease sweat production. - **Medications:** Oral anticholinergic drugs are sometimes prescribed, though they may have side effects. - **Botulinum toxin injections:** Botox can temporarily block the nerves that stimulate sweat glands, providing relief for several months. - **Iontophoresis:** Primarily effective for other regions but less so on the face. - **Lifestyle modifications:** Wearing breathable clothing, avoiding known triggers, and managing stress can help control symptoms. - **Surgical options:** Rarely considered; methods include sympathectomy, which involves nerve surgery to reduce sweating. It is essential for individuals experiencing these symptoms to consult a healthcare professional to determine the most appropriate and personalized treatment plan.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is L74.511 a billable ICD-10 code?
Yes, L74.511 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report L74.511?
Clinical documentation must specify the nature of Primary focal hyperhidrosis, face and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

primary focal